跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lignocaine Gel 2% - HSA Drug Approval Details
Approvals
/
HSA
/
Lignocaine Gel 2%
Approved
THERAPEUTIC
Lignocaine Gel 2%
Pfizer (Perth) Pty Ltd (Parametric release)
🇸🇬 Health Sciences Authority
Approval Date
Jan 10, 2011
Approval ID
1268a3ffb677ab7d
Company
Pfizer (Perth) Pty Ltd (Parametric release)
Type
Therapeutic
Approval Details
Approval Id
1268a3ffb677ab7d
Drug Name
Lignocaine Gel 2%
Product Name
Lignocaine Gel 2%
Approval Number
SIN13908P
Approval Date
2011-01-10
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
GEL
Route Of Administration
TOPICAL
Atc Code
N01BB02
Atc Item Name
lidocaine
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Company Detail Path
/organization/pfizer-private-limited
Active Ingredients
Lignocaine (as base)
20mg/g
LIGNOCAINE (AS BASE)
20 MG/G
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 10, 2011
Approval ID
1268a3ffb677ab7d
Type
Therapeutic
Back to HSA Approvals